Cerence Q3 2024 Adj. EPS $(0.01) Misses $0.05 Estimate, Sales $44.000M Miss $68.469M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cerence (NASDAQ:CRNC) reported Q3 2024 adjusted EPS of $(0.01), missing the $0.05 estimate by 120%. Sales were $44M, missing the $68.469M estimate by 35.74% and down 28.64% from last year's $61.66M.
August 08, 2024 | 11:04 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cerence reported Q3 2024 adjusted EPS of $(0.01), missing the $0.05 estimate by 120%. Sales were $44M, missing the $68.469M estimate by 35.74% and down 28.64% from last year's $61.66M.
Cerence's significant misses on both EPS and sales estimates, along with a notable year-over-year sales decline, are likely to negatively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100